Allison Taylor

Conference Blood · November 3, 2025 AbstractBackground: Randomized trials demonstrate that patients with AML hospitalized for intensive chemotherapy benefit significantly from ... Full text Cite

Impact of recipient sociodemographic factors on allogeneic transplant conditioning intensity and survival outcomes in myeloid malignancies: A secondary analysis of CIBMTR data

Conference Blood · November 3, 2025 AbstractIntroduction: Sociodemographic factors influence all aspects of the allogeneic hematopoietic cell transplantation (HCT) process. Th ... Full text Cite

Real-world survival outcomes with first-line venetoclax therapy in AML

Conference Blood · November 3, 2025 AbstractIntroduction: Venetoclax, a selective BCL-2 inhibitor combined with a hypomethylating agent (azacitidine or decitabine), has become ... Full text Cite

Diagnostic Journeys in Myeloma: A Qualitative Exploration of Barriers and Facilitators

Conference CLINICAL LYMPHOMA MYELOMA & LEUKEMIA · September 2025 Link to item Cite

Impact of Sociodemographic Factors on Conditioning Intensity and Outcomes of Hematopoietic Cell Transplant Recipients With Myeloid Malignancies

Conference CLINICAL LYMPHOMA MYELOMA & LEUKEMIA · September 2025 Link to item Cite

Treatment Experience of Patients with Acute Myeloid Leukemia in the Era of Novel Therapies: A Longitudinal Electronic Patient-Reported Outcomes Study

Conference Blood · November 5, 2024 Background: Since 2017, novel therapies for acute myeloid leukemia (AML) have emerged as options for patients unfit for high-intensity induction chemotherapy. However, much of our current ... Full text Cite

Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States

Conference Blood · November 5, 2024 Background: Survivors of allogeneic hematopoietic cell transplantation (HCT) are at risk for treatment-related late effects. Published recommendations for screening/prevention of late com ... Full text Cite

Real-World Clinician Adherence to Screening and Preventive Practices Guidelines for Subsequent Neoplasms Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States

Conference Blood · November 5, 2024 Background: Prior studies have reported variable adherence to screening/prevention guidelines from allogeneic hematopoietic cell transplant (HCT) survivors' perspective (Khera N et al. Bi ... Full text Cite

Self-Reported Stress Exposures Are Associated with Increased Risk of Dyspepsia and Gastritis in Patients Undergoing Upper Endoscopy

Conference AMERICAN JOURNAL OF GASTROENTEROLOGY · October 2023 Link to item Cite

S1857 Self-Reported Stress Exposures Are Associated with Increased Risk of Dyspepsia and Gastritis in Patients Undergoing Upper Endoscopy

Conference American Journal of Gastroenterology · October 2023 Full text Cite

Overall Survival of Adult Acute Lymphoblastic Leukemia (ALL) Patients By Facility Volume and Type: A National Cancer Database Report

Conference Blood · November 15, 2022 Full text Cite

Impact of Treating Facility on Overall Survival and Treatment in Multiple Myeloma (MM) Using National Cancer Database (NCDB)

Conference Blood · November 5, 2021 AbstractIntroduction:Prior studies have shown poorer outcomes in Black and Hispanic patients and in patients with lower median household income and education 1-5. In MM, we h ... Full text Cite

Impact of Treatment Facility Chracteristics on Patient (Pt) Outcomes in Acute Myeloid Leukemia (AML) Using Data from the National Cancer Database (NCDB)

Conference Blood · November 5, 2020 IntroductionThe literature suggests a widespread reduction in the availability and accessibility of newer treatment options among marginalized groups in AML. Studies from large national databases point to lower soci ... Full text Cite